Orellanine
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Orellanine
- DrugBank Accession Number
- DB19263
- Background
Orellanine is under investigation in clinical trial NCT05287945 (Study of Orellanine in Metastatic Clear-cell or Papillary Renal Cell Carcinoma).
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 252.182
Monoisotopic: 252.038235986 - Chemical Formula
- C10H8N2O6
- Synonyms
- (2,2'-bipyridine)-3,3',4,4'-tetrol, 1,1'-dioxide
- 3,3',4,4'-tetrahydroxy-2,2'-bipyridine-1,1'-dioxide
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 082U1GSX3D
- CAS number
- 37338-80-0
- InChI Key
- JEWWXPOUSBVQKG-UHFFFAOYSA-N
- InChI
- InChI=1S/C10H8N2O6/c13-5-1-3-11(17)7(9(5)15)8-10(16)6(14)2-4-12(8)18/h1-4,13-16H
- IUPAC Name
- SMILES
- OC1=CC=[N+]([O-])C(=C1O)C1=C(O)C(O)=CC=[N+]1[O-]
References
- General References
- Not Available
- External Links
- ChemSpider
- 10266115
- ChEMBL
- CHEMBL2152646
- ZINC
- ZINC000150339637
- Wikipedia
- Orellanine
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data1, 2 Recruiting Treatment Renal Cell Carcinoma (RCC) 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at July 12, 2024 16:28 / Updated at July 13, 2024 15:36